Literature DB >> 18647634

Estimating the impact of childhood influenza vaccination programmes in England and Wales.

Emilia Vynnycky1, Richard Pitman, Ruby Siddiqui, Nigel Gay, W John Edmunds.   

Abstract

There is increasing interest in routine vaccination of children against influenza. We use an age-structured model to demonstrate that the long-term incidence of influenza A could decrease by 11-21% in the overall population by vaccinating individuals aged 6 to <24 months, and by 22-38% and 65-97% through targeting those aged 6 to <60 months and 6 months to 16 years, respectively. The corresponding reductions predicted for influenza B were 25-35%, 44-69% and 85-96%, respectively. These results are sensitive to assumptions about contact patterns and several parameters, including the vaccine efficacy among those aged <24 months, require further study. Consistently high levels of vaccination coverage among pre-school children has the potential to bring benefits to both those vaccinated and the community.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18647634     DOI: 10.1016/j.vaccine.2008.06.101

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  39 in total

Review 1.  Economic evaluations of childhood influenza vaccination: a critical review.

Authors:  Anthony T Newall; Mark Jit; Philippe Beutels
Journal:  Pharmacoeconomics       Date:  2012-08-01       Impact factor: 4.981

Review 2.  The use of mathematical models to inform influenza pandemic preparedness and response.

Authors:  Joseph T Wu; Benjamin J Cowling
Journal:  Exp Biol Med (Maywood)       Date:  2011-07-04

3.  Understanding the cost-effectiveness of influenza vaccination in children: methodological choices and seasonal variability.

Authors:  Anthony T Newall; Juan Pablo Dehollain; Prudence Creighton; Philippe Beutels; James G Wood
Journal:  Pharmacoeconomics       Date:  2013-08       Impact factor: 4.981

4.  Estimates of the Public Health Impact of a Pediatric Vaccination Program Using an Intranasal Tetravalent Live-Attenuated Influenza Vaccine in Belgium.

Authors:  Laetitia Gerlier; Mark Lamotte; Sofia Dos Santos Mendes; Oliver Damm; Markus Schwehm; Martin Eichner
Journal:  Paediatr Drugs       Date:  2016-08       Impact factor: 3.022

5.  Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic.

Authors:  Joseph T Wu; Cheuk Kwong Lee; Benjamin J Cowling; Kwok Yung Yuen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

6.  Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza.

Authors:  Ashleigh R Tuite; Amy L Greer; Michael Whelan; Anne-Luise Winter; Brenda Lee; Ping Yan; Jianhong Wu; Seyed Moghadas; David Buckeridge; Babak Pourbohloul; David N Fisman
Journal:  CMAJ       Date:  2009-12-03       Impact factor: 8.262

7.  Real-time epidemic monitoring and forecasting of H1N1-2009 using influenza-like illness from general practice and family doctor clinics in Singapore.

Authors:  Jimmy Boon Som Ong; Mark I-Cheng Chen; Alex R Cook; Huey Chyi Lee; Vernon J Lee; Raymond Tzer Pin Lin; Paul Ananth Tambyah; Lee Gan Goh
Journal:  PLoS One       Date:  2010-04-14       Impact factor: 3.240

Review 8.  Burden of paediatric influenza in Western Europe: a systematic review.

Authors:  Evgeniya N Antonova; Catherine E Rycroft; Christopher S Ambrose; Terho Heikkinen; Nicola Principi
Journal:  BMC Public Health       Date:  2012-11-12       Impact factor: 3.295

9.  Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States.

Authors:  Nicole E Basta; Dennis L Chao; M Elizabeth Halloran; Laura Matrajt; Ira M Longini
Journal:  Am J Epidemiol       Date:  2009-08-13       Impact factor: 4.897

10.  An approximation of herd effect due to vaccinating children against seasonal influenza - a potential solution to the incorporation of indirect effects into static models.

Authors:  Ilse Van Vlaenderen; Laure-Anne Van Bellinghen; Genevieve Meier; Barbara Poulsen Nautrup
Journal:  BMC Infect Dis       Date:  2013-01-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.